Replies to post #30243 on Biotech Values

[masterlongevity]

I added a little bit to my DNA position yesterday.

I think in the next two weeks, the following positive catalysts could push the price up around 10% (JMHO)

Lucentis approval with a clean and wide label (1+ billion opp)
Avastin approval in 2nd line mCRC (250 million opp)
Herceptin approval in adjuvant BC (1+ billion opp)